U.S. markets closed
  • S&P Futures

    4,219.00
    +5.25 (+0.12%)
     
  • Dow Futures

    33,809.00
    +48.00 (+0.14%)
     
  • Nasdaq Futures

    14,139.25
    +9.25 (+0.07%)
     
  • Russell 2000 Futures

    2,283.50
    +2.60 (+0.11%)
     
  • Crude Oil

    73.64
    -0.02 (-0.03%)
     
  • Gold

    1,786.20
    +3.30 (+0.19%)
     
  • Silver

    25.96
    -0.07 (-0.25%)
     
  • EUR/USD

    1.1909
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.4840
    +0.0340 (+2.34%)
     
  • Vix

    17.89
    -2.81 (-13.57%)
     
  • GBP/USD

    1.3915
    -0.0018 (-0.13%)
     
  • USD/JPY

    110.4400
    +0.1420 (+0.13%)
     
  • BTC-USD

    32,709.52
    -2,290.80 (-6.55%)
     
  • CMC Crypto 200

    787.39
    -62.96 (-7.40%)
     
  • FTSE 100

    7,062.29
    +44.82 (+0.64%)
     
  • Nikkei 225

    28,802.24
    +791.31 (+2.83%)
     

The Biggest Loser With Johnson & Johnson's COVID Vaccine Manufacturing Woes

·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Although Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine is no longer on pause, the healthcare giant still faces some major production challenges. In this Motley Fool Live video recorded on April 21, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the biggest loser with J&J's COVID-19 vaccine manufacturing woes. Keith Speights: We've had news already about the Baltimore facility that was manufacturing Johnson & Johnson's COVID-19 vaccine being shut down while an FDA inspection was under way.